- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06759987
Construction and Application of a Self-Care Behavior Intervention Scheme for Chronic Heart Failure Patients Based on Interaction Model of Client Health Behavior
December 30, 2024 updated by: Zhi-fen Feng
The purpose of this study, which will last for 3 months, is to investigate the effect of the intervention based on the interaction model of health behavior on patients' disease perception, heart failure self-care level, quality of life and service satisfaction.
If you have any questions or difficulties, you can withdraw from this study at any time, which will not affect your treatment and care; The purpose of this study is to improve your level of self-care, prevent your readmission to the hospital, and do not harm your physical and mental health, nor negatively affect the patient's relationship with care; Your participation in the study and the personal data in the study are confidential, and any public report on the results of this study will not disclose your personal identity.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Henan
-
Kaifeng, Henan, China, 475004
- Institute of Nursing and Health, School of Nursing and Health,Henan University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients diagnosed with CHF according to the New York Heart Association (NYHA) functional classification of II-III.
- Age ≥ 18 years, stable condition, clear consciousness, normal language and written expression abilities, no communication barriers, able to understand and accurately complete questionnaires.
- Informed consent and voluntary participation.
Exclusion Criteria:
- -Patients with complications such as renal or hepatic insufficiency, a history of mental disorders, or currently experiencing mental disorders, or critically ill.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: control group
The control group received routine care.
|
|
|
Experimental: intervention group
The intervention group received the self-care behavior intervention program based on the interaction model of health behavior.
|
The intervention group received the self-care behavior intervention program based on the interaction model of health behavior
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Chinese Version of the Self-Care of Heart Failure Index (SCHFI)
Time Frame: Baseline, one month and three months
|
Baseline, one month and three months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Brief Illness Perception Questionnaire (BIPQ)
Time Frame: Baseline, one month and three months
|
Baseline, one month and three months
|
|
Minnesota Living with Heart Failure Quality of Life Questionnaire (MLHFQ)
Time Frame: Baseline, one month and three months
|
Baseline, one month and three months
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Unplanned Readmission
Time Frame: one month and three months
|
one month and three months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2023
Primary Completion (Actual)
June 30, 2023
Study Completion (Actual)
October 31, 2023
Study Registration Dates
First Submitted
December 30, 2024
First Submitted That Met QC Criteria
December 30, 2024
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 30, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUSOM2023-441
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Heart Failure
-
Noah LabsHospital Clinic of Barcelona; Maastricht University; Zuyderland Medical CentreActive, not recruitingHeart Failure | Chronic Heart Failure | Chronic Heart DiseaseSpain, Netherlands
-
BayerCompletedChronic Heart Failure | Chronic Heart Failure With Reduced Ejection FractionJapan
-
BayerActive, not recruitingChronic Heart Failure With Reduced Ejection Fraction | Worsening Chronic Heart FailureIndia
-
Maastricht University Medical CenterUniversity Medical Center Groningen; Maastricht UniversityWithdrawnChronic Heart Failure | Acute Decompensated Heart FailureNetherlands
-
Melana Yuzefpolskaya, MDRecruitingChronic Heart FailureUnited States
-
BayerRecruitingChronic Heart FailureSouth Korea
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
CHFDX,Inc.University of South Florida; Tampa General HospitalRecruitingDecompensated Chronic Heart FailureUnited States
-
Medical University of ViennaCompleted
-
Maastricht University Medical CenterUniversity College Dublin; RWTH Aachen University; Queen's University, BelfastCompletedChronic Heart FailureNetherlands, Germany, Ireland, United Kingdom
Clinical Trials on self-care behavior intervention
-
University of North Carolina, Chapel HillCenters for Disease Control and PreventionCompleted
-
National Taiwan University HospitalCompleted
-
National Taiwan University HospitalNational Science Council, TaiwanUnknownPremenstrual SyndromeTaiwan
-
The University of Texas Health Science Center,...Harris Health SystemCompleted
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); The Fenway InstituteUnknownMedication Adherence | Body Image DisturbanceUnited States
-
Istanbul University - Cerrahpasa (IUC)CompletedUrinary Tract Infection During PregnancyTurkey
-
Boston CollegeJoslin Diabetes CenterCompleted
-
Baylor UniversityCompletedHIV | Implementation Science | Self Sampling | Communication ModelGhana
-
Mayo ClinicCompletedAlzheimer Disease | Cognitive Symptom | Pre Senile DementiaUnited States
-
University of ÉvoraRecruiting